|
|
Interactions
with Chromium | |
Biguanide
Antidiabetic Agents;
Insulin
Preparations;
Sulfonylureas
A total of 115 patients with either Type I or Type II diabetes who were
treated with chromium (200 mcg/day) required lower doses of insulin,
sulfonylurea drugs, and metformin (Ravina and Slezack 1993). The glycemic
response to chromium treatment was greater for patients with Type II diabetes
(57.2%). Chromium picolinate may benefit patients with Type II diabetes by
increasing insulin sensitivity and stimulating insulin receptor sites (McCarty
1998). Calcium
Carbonate
Administration of 1 mL antacid suspension of calcium carbonate (150 mg) prior
to treatment with 20 uCi 51chromium chloride minimized accumulation
of chromium in the kidneys, testes, and spleen in male rats (Seaborn and
Stoecker 1990). These findings are supported by another study with female rats
given antacid (40 mg) by gastric intubation (0.5 mL) followed orally by 55 uCi
51chromium chloride; chromium absorption was hindered by pretreatment
with antacid (Davis et al. 1995). |
|
|
References |
|
Davis ML, Seaborn CD, Stoecker BJ. Effects of over-the counter drugs on
51chromium retention and urinary excretion in rats. Nutr Res.
1995;15:201-210.
McCarty MF. Complementary measures for promoting insulin sensitivity in
skeletal muscle. Med Hypotheses. 1998;51(6):451-464.
Ravina A, Slezack L. Chromium in the treatment of clinical diabetes mellitus.
Harefuah. 1993;125(5-6):142-145,191.
Seaborn CD, Stoecker BJ. Effects of antacid or ascorbic acid on tissue
accumulation and urinary excretion of chromium-51. Nutr Res.
1990;10:1401-1408. |
|
Copyright © 2000 Integrative Medicine
Communications This publication contains
information relating to general principles
of medical care that should not in any event be construed as specific
instructions for individual patients. The publisher does not accept any
responsibility for the accuracy of the information or the consequences arising
from the application, use, or misuse of any of the information contained herein,
including any injury and/or damage to any person or property as a matter of
product liability, negligence, or otherwise. No warranty, expressed or implied,
is made in regard to the contents of this material. No claims or endorsements
are made for any drugs or compounds currently marketed or in investigative use.
The reader is advised to check product information (including package inserts)
for changes and new information regarding dosage, precautions, warnings,
interactions, and contraindications before administering any drug, herb, or
supplement discussed herein. | |